Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective feticide in twin pregnancy: a case report.
Svigos J, Rudzki Z, Morris D. Svigos J, et al. Among authors: rudzki z. Med J Aust. 1990 May 7;152(9):492, 494. doi: 10.5694/j.1326-5377.1990.tb125314.x. Med J Aust. 1990. PMID: 2381343
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice.
Oldreive CE, Skowronska A, Davies NJ, Parry H, Agathanggelou A, Krysov S, Packham G, Rudzki Z, Cronin L, Vrzalikova K, Murray P, Odintsova E, Pratt G, Taylor AM, Moss P, Stankovic T. Oldreive CE, et al. Among authors: rudzki z. Dis Model Mech. 2015 Nov;8(11):1401-12. doi: 10.1242/dmm.021147. Epub 2015 Aug 20. Dis Model Mech. 2015. PMID: 26398941 Free PMC article.
Sclerosing angiomatoid nodular transformation of the spleen.
Murthy V, Miller B, Nikolousis EM, Pratt G, Rudzki Z. Murthy V, et al. Among authors: rudzki z. Clin Case Rep. 2015 Oct;3(10):888-90. doi: 10.1002/ccr3.325. Epub 2015 Sep 10. Clin Case Rep. 2015. PMID: 26509031 Free PMC article.
Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival.
Maybury BD, James L, Phillips N, Venkatadasari I, Qureshi I, Riley J, Talbot G, Moosai S, Giles H, Chadderton N, Dowds J, Rakesh P, Crosland H, Haslam A, Lane S, Vega Gonzalez M, Davies D, Cherian G, Shenouda A, Kaudlay P, Starczynski J, Rudzki Z, Chaganti S. Maybury BD, et al. Among authors: rudzki z. Blood. 2024 Jul 4;144(1):113-117. doi: 10.1182/blood.2024024048. Blood. 2024. PMID: 38648564
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.
Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K, Herrmann R, Lynch KP, Hughes TP. Branford S, et al. Among authors: rudzki z. Blood. 2002 May 1;99(9):3472-5. doi: 10.1182/blood.v99.9.3472. Blood. 2002. PMID: 11964322 Free article.
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.
Branford S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J, Taylor K, Herrmann R, Seymour JF, Arthur C, Joske D, Lynch K, Hughes T. Branford S, et al. Among authors: rudzki z. Blood. 2003 Jul 1;102(1):276-83. doi: 10.1182/blood-2002-09-2896. Epub 2003 Mar 6. Blood. 2003. PMID: 12623848 Free article.
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Branford S, Rudzki Z, Parkinson I, Grigg A, Taylor K, Seymour JF, Durrant S, Browett P, Schwarer AP, Arthur C, Catalano J, Leahy MF, Filshie R, Bradstock K, Herrmann R, Joske D, Lynch K, Hughes T. Branford S, et al. Among authors: rudzki z. Blood. 2004 Nov 1;104(9):2926-32. doi: 10.1182/blood-2004-03-1134. Epub 2004 Jul 15. Blood. 2004. PMID: 15256429 Free article.
116 results